Cost-effectiveness of generic celecoxib in knee osteoarthritis for average-risk patients: a model-based evaluation

Losina E.; Usiskin I. M.; Smith S. R.; Sullivan J. K.; Smith K. C.; Hunter D. J.; Messier S. P.; Paltiel A. D.; Katz J. N.

首页> 外文期刊>Osteoarthritis and cartilage >Cost-effectiveness of generic celecoxib in knee osteoarthritis for average-risk patients: a model-based evaluation

【24h】

Cost-effectiveness of generic celecoxib in knee osteoarthritis for average-risk patients: a model-based evaluation

机译：通用塞克西布在膝关节骨关节炎的平均风险患者的成本效益：基于模型的评估

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: The cost-effectiveness of the recently-introduced generic celecoxib in knee OA has not been examined.

机译：目的：膝关节OA中最近引入的通用Celecoxib的成本效益尚未进行检查。

著录项

来源
《Osteoarthritis and cartilage》 |2018年第5期|共10页
作者
Losina E.; Usiskin I. M.; Smith S. R.; Sullivan J. K.; Smith K. C.; Hunter D. J.; Messier S. P.; Paltiel A. D.; Katz J. N.;
展开▼
作者单位

Brigham &

Womens Hosp Dept Orthopaed Surg Orthopaed &

Arthrit Ctr Outcomes Res OrACORe Policy &

Brigham &

Womens Hosp Dept Orthopaed Surg Orthopaed &

Arthrit Ctr Outcomes Res OrACORe Policy &

Brigham &

Womens Hosp Dept Orthopaed Surg Orthopaed &

Arthrit Ctr Outcomes Res OrACORe Policy &

Brigham &

Womens Hosp Dept Orthopaed Surg Orthopaed &

Arthrit Ctr Outcomes Res OrACORe Policy &

Brigham &

Womens Hosp Dept Orthopaed Surg Orthopaed &

Arthrit Ctr Outcomes Res OrACORe Policy &

Univ Sydney Kolling Inst Inst Bone &

Joint Res Sydney NSW Australia;

Wake Forest Univ Dept Hlth &

Exercise Sci Winston Salem NC 27109 USA;

Yale Sch Management Yale Sch Publ Hlth New Haven CT USA;

Brigham &

Womens Hosp Div Rheumatol 75 Francis St Boston MA 02115 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类骨科学（运动系疾病、矫形外科学）;
关键词
Osteoarthritis; Cost-effectiveness; Celecoxib; NSAIDs;

机译：骨关节炎;成本效益;celecoxib;nsaids;

相似文献

外文文献
中文文献
专利

1. Cost-effectiveness of generic celecoxib in knee osteoarthritis for average-risk patients: a model-based evaluation [J] . Losina E., Usiskin I. M., Smith S. R., Osteoarthritis and cartilage . 2018,第5期

机译：通用塞克西布在膝关节骨关节炎的平均风险患者的成本效益：基于模型的评估
2. The Cost-Effectiveness of Surgical Treatment of Medial Unicompartmental Knee Osteoarthritis in Younger Patients A Computer Model-Based Evaluation [J] . Konopka Joseph F., Gomoll Andreas H., Thornhill Thomas S., The Journal of Bone and Joint Surgery. American Volume . 2015,第10期

机译：青年患者手术治疗内侧单室膝关节骨关节炎的成本-效果基于计算机模型的评估
3. Model-based evaluation of cost-effectiveness of nerve growth factor inhibitors in knee osteoarthritis: impact of drug cost, toxicity, and means of administration [J] . Losina E., Michl G., Collins J. E., Osteoarthritis and cartilage . 2016,第5期

机译：基于模型的膝关节骨关节炎中神经生长因子抑制剂成本效益的评估：药物成本，毒性和给药方式的影响
4. Customized Knee Brace for Osteoarthritis Patient Using 3D Printing A Customized Knee Brace Using 3D Printing : A Customized Knee Brace Using 3D Printing [C] . C. Jim Elliot, V Gayathry, A Pannertamil, International Conference on Intelligent Communication Technologies and Virtual Mobile Networks . 2021

机译：使用3D打印使用3D打印定制膝盖支架的骨关节炎患者定制膝关节膝关节：使用3D打印的定制膝盖支架
5. Cost-effectiveness of glucosamine, chondroitin sulfate, their combination, celecoxib, non-selective non- steroidal antiinflammatory drugs, and placebo in treating knee osteoarthritis. [D] . Garg, Vishvas. 2014

机译：氨基葡萄糖，硫酸软骨素，它们的组合，塞来昔布，非选择性非甾体抗炎药和安慰剂在治疗膝部骨关节炎中的成本效益。
6. Cost-effectiveness of generic celecoxib in knee osteoarthritis for average-risk patients: A model-based evaluation [O] . Elena Losina, Ilana M. Usiskin, Savannah R. Smith, -1

机译：普通塞来昔布治疗膝关节骨关节炎的平均风险：基于模型的评估
7. Cost-effectiveness of generic celecoxib in knee osteoarthritis for average-risk patients: a model-based evaluation [O] . E. Losina, I.M. Usiskin, S.R. Smith, 2018

机译：膝关节骨关节炎的普通塞克西布的成本效益平均风险患者：基于模型的评估

Cost-effectiveness of generic celecoxib in knee osteoarthritis for average-risk patients: a model-based evaluation

摘要

著录项

相似文献

相关主题

期刊订阅